Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis

Front Pharmacol. 2021 Apr 20:12:619344. doi: 10.3389/fphar.2021.619344. eCollection 2021.

Authors

Rodrigo R N Rizzo^{1

2}, Michael A Wewege^{1

2}, Hayley B Leake^{1

3}, James H McAuley^{1

2}

Affiliations

¹ Centre for Pain IMPACT, Neuroscience Research Australia, Sydney, NSW, Australia.
² School of Health Sciences, University of NSW, Sydney, NSW, Australia.
³ IIMPACT in Health, University of SA, Adelaide, NSW, Australia.

No abstract available

Keywords: anti-nerve growth factor antibody; chronic low-back pain; meta-analysis; osteoarthritis pain; systematic review.

Publication types

Comment